These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10021914)

  • 1. In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model.
    Xu ZQ; Hollingshead MG; Borgel S; Elder C; Khilevich A; Flavin MT
    Bioorg Med Chem Lett; 1999 Jan; 9(2):133-8. PubMed ID: 10021914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).
    Zembower DE; Liao S; Flavin MT; Xu ZQ; Stup TL; Buckheit RW; Khilevich A; Mar AA; Sheinkman AK
    J Med Chem; 1997 Mar; 40(6):1005-17. PubMed ID: 9083491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-HIV activities of HIV-1 reverse transcriptase inhibitor racemic 11-demethyl-calanolide A].
    Peng ZG; Chen HS; Wang L; Liu G
    Yao Xue Xue Bao; 2008 May; 43(5):456-60. PubMed ID: 18717330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI.
    Xu ZQ; Buckheit RW; Stup TL; Flavin MT; Khilevich A; Rizzo JD; Lin L; Zembower DE
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2179-84. PubMed ID: 9873509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A.
    Currens MJ; Mariner JM; McMahon JB; Boyd MR
    J Pharmacol Exp Ther; 1996 Nov; 279(2):652-61. PubMed ID: 8930168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.
    Currens MJ; Gulakowski RJ; Mariner JM; Moran RA; Buckheit RW; Gustafson KR; McMahon JB; Boyd MR
    J Pharmacol Exp Ther; 1996 Nov; 279(2):645-51. PubMed ID: 8930167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical library and structure-activity relationships of 11-demethyl-12-oxo calanolide A analogues as anti-HIV-1 agents.
    Ma T; Liu L; Xue H; Li L; Han C; Wang L; Chen Z; Liu G
    J Med Chem; 2008 Mar; 51(5):1432-46. PubMed ID: 18284187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.
    Buckheit RW; Russell JD; Xu ZQ; Flavin M
    Antivir Chem Chemother; 2000 Sep; 11(5):321-7. PubMed ID: 11142630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase.
    Quan Y; Motakis D; Buckheit R; Xu ZQ; Flavin MT; Parniak MA; Wainberg MA
    Antivir Ther; 1999; 4(4):203-9. PubMed ID: 10723499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Xu ZQ; Barrow WW; Suling WJ; Westbrook L; Barrow E; Lin YM; Flavin MT
    Bioorg Med Chem; 2004 Mar; 12(5):1199-207. PubMed ID: 14980631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection.
    Alder J; Hui YH; Clement J
    Antiviral Res; 1995 May; 27(1-2):85-97. PubMed ID: 7486961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers.
    Eiznhamer DA; Creagh T; Ruckle JL; Tolbert DT; Giltner J; Dutta B; Flavin MT; Jenta T; Xu ZQ
    HIV Clin Trials; 2002; 3(6):435-50. PubMed ID: 12501127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
    Fridkin M; Tsubery H; Tzehoval E; Vonsover A; Biondi L; Filira F; Rocchi R
    J Pept Sci; 2005 Jan; 11(1):37-44. PubMed ID: 15635725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
    Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
    J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B.
    Galinis DL; Fuller RW; McKee TC; Cardellina JH; Gulakowski RJ; McMahon JB; Boyd MR
    J Med Chem; 1996 Oct; 39(22):4507-10. PubMed ID: 8893846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus.
    Xu ZQ; Kern ER; Westbrook L; Allen LB; Buckheit RW; Tseng CK; Jenta T; Flavin MT
    Antivir Chem Chemother; 2000 Jan; 11(1):23-9. PubMed ID: 10693651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anti-AIDS drugs in conventional mice implanted with a permeable membrane device containing human T cells infected with HIV.
    Quenelle DC; Keith KA; Dunleavy KE; Taylor BA; Bowdon BJ; Brazier AD; Mullon CJ; HarrisRE ; Allen LB
    Antiviral Res; 1997 Jul; 35(2):123-9. PubMed ID: 9217249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant Coumarins with Anti-HIV Activity: Isolation and Mechanisms of Action.
    Sharapov AD; Fatykhov RF; Khalymbadzha IA; Zyryanov GV; Chupakhin ON; Tsurkan MV
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
    Zhou T; Xie L
    Yao Xue Xue Bao; 2004 Aug; 39(8):666-72. PubMed ID: 15563074
    [No Abstract]   [Full Text] [Related]  

  • 20. Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile.
    Xue H; Lu X; Zheng P; Liu L; Han C; Hu J; Liu Z; Ma T; Li Y; Wang L; Chen Z; Liu G
    J Med Chem; 2010 Feb; 53(3):1397-401. PubMed ID: 20050672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.